Page last updated: 2024-10-30

mepivacaine and Cancer of the Uterus

mepivacaine has been researched along with Cancer of the Uterus in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sagiv, R1
Sadan, O1
Boaz, M1
Dishi, M1
Schechter, E1
Golan, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A New Approach to Office Hysteroscopy Compared With Traditional Hysteroscopy[NCT00319410]Phase 3130 participants Interventional2005-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mepivacaine and Cancer of the Uterus

ArticleYear
A new approach to office hysteroscopy compared with traditional hysteroscopy: a randomized controlled trial.
    Obstetrics and gynecology, 2006, Volume: 108, Issue:2

    Topics: Adult; Ambulatory Care; Anesthetics, Local; Cervix Uteri; Female; Humans; Hysteroscopy; Injections;

2006